Comparative Study of the Pharmacokinetics and Bioequivalence of Two Flupentixol Formulations

Inclusion Criteria: * body mass index (BMI) of ≥18.5 and ≤30 kg/m2 * The subject is, in the opinion of the investigator, generally healthy based on medical history, physical examination, vital signs, electrocardiogram (ECG), and the results of the haematology, clinical chemistry, urinalysis, serology, and other laboratory tests. Exclusion Criteria: * The subject is pregnant or breastfeeding. * The subject has taken any investigational medicinal products 3 months prior to the first dose * The subject has tested positive at the Screening Visit or at the Baseline Visit for drugs of abuse (opiates, methadone, cocaine, amphetamines \[including ecstasy\], barbiturates, benzodiazepines, and cannabinoids). Other protocol defined inclusion and exclusion criteria may apply